Is this you? Create Your Porfile
Avatar

Auguet Michel

Ipsen

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Auguet Michel is active.

Explore More

Publication

Featured researches published by Auguet Michel.

Archive | 1990

Agents for blocking endothelin derived relaxing factor

Braquet Pierre; Chabrier De Lassauniere Pierre; Guillon Jean-Michel; Auguet Michel

Toxicon | 2008

Analgesic effects of Botulinum toxin A in an inflammatory pain model in rats: Comparison of Dysport® and Botox®; synergistic interaction with morphine

Auguet Michel; Favre-Guilmard Christine; Chabrier De Lassauniere Pierre-Etienne

Archive | 2001

alpha1-adrenergic receptor antagonists

Bigg Dennis; Chabrier De Lassauniere Pierre; Auvin Serge; Auguet Michel

Archive | 2001

PRODUIT COMPRENANT AU MOINS UNE SUBSTANCE INHIBITRICE DES NO SYNTHASES EN ASSOCIATION AVEC AU MOINS UNE SUBSTANCE INHIBITRICE DES PHOSPHOLIPASES A2

Auguet Michel; Chabrier De Lassauniere Pierre

Archive | 2000

Compositions containing nitrogen monoxide synthase inhibitor and dithiol having metabolic antioxidant activity, useful for treating cardio and cerebrovascular disorders, inflammatory disorders or auto-immune diseases

Auguet Michel; Harnett Jeremiah; Chabrier De Lassauniere Pierre

Archive | 1991

AGENTS BLOQUANTS DE L'EFFET OU DE LA FORMATION DU FACTEUR EDRF POUR LE TRAITEMENT DES CHOCS.

Braquet Pierre; Chabrier De Lassauniere Pierre; Guillon Jean-Michel; Auguet Michel

Archive | 2000

Liponsaürederivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Harnett Jeremiah; Auguet Michel; Chabrier De Lassauniere Pierre

Archive | 1990

Blockierungsmittel der edrf-wirkung oder -bildung fuer die behandlung von schockzustaenden

Braquet Pierre; Chabrier De Lassauniere Pierre; Guillon Jean-Michel; Auguet Michel

Archive | 2017

Uso terapéutico de la neurotoxina botulínica de Tipo A en el tratamiento del dolor asociado a la neuropatía diabética

Favre Christine; Auguet Michel; Chabrier De Lassauniere Pierre-Etienne

Archive | 2015

Uso terapéutico de al menos una neurotoxina botulínica en el tratamiento del dolor inducido por al menos un agente anticanceroso

Favre Christine; Auguet Michel; Chabrier De Lassauniere Pierre-Etienne

Explore More

Collaboration

Dive into the Auguet Michel's collaboration.

Top Co-Authors
Avatar

Chabrier De Lassauniere Pierre

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Harnett Jeremiah

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Chabrier De Lassauniere Pierre-Etienne

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Bigg Dennis

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Favre Christine

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Camara Jose

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Favre-Guilmard Christine

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Prevost Gregoire

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Gordon Thomas

Ipsen

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge